Luc Mathis is the former CEO of Calyxt (NASDAQ:CLXT) – a leading company in gene editing for agriculture. Luc holds a PhD in Biology from the Pasteur Institute (France) and did post doctoral studies at Caltech (USA). Luc Mathis has 15 years of experience in business development and startup management in biotechnology. He is also board member of Micropep, an agriculture biotech company and founding CEO of Symflor, a Cornell microbiome company. Most recently, Luc has been CBO of Global Bioenergies. As strategic advisor of Meiogenix, Luc helped its founders close a significant R&D agreement with Bayer Crop Science and a strategic partnership with Cornell University.